Jim Simons Vertex Pharmaceuticals Inc Transaction History

Renaissance Technologies LLC

$63.6 Billion
Q1 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,580,488 shares of VRTX stock, worth $704 Million. This represents 1.04% of its overall portfolio holdings.

Number of Shares

1,580,488

Previous 1,591,688 0.7%

Holding current value

$704 Million

Previous $648 Million 2.01%

% of portfolio

1.04%

Previous 1.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$407.69 - $446.08 $4.57 Million - $5 Million	-11,200 Reduced 0.7%	1,580,488 $661 Million
Q4 2023 Feb 13, 2024	SELL	$343.0 - $410.68 $24.8 Million - $29.7 Million	-72,400 Reduced 4.35%	1,591,688 $648 Million
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $133 Million - $142 Million	391,927 Added 30.81%	1,664,088 $579 Million
Q2 2023 Aug 11, 2023	SELL	$314.42 - $351.91 $39.5 Million - $44.2 Million	-125,574 Reduced 8.98%	1,272,161 $448 Million
Q1 2023 May 12, 2023	SELL	$283.23 - $323.1 $240 Million - $274 Million	-849,017 Reduced 37.79%	1,397,735 $440 Million

Q4 2022 Feb 13, 2023	BUY	$285.76 - $321.48 $30.8 Million - $34.7 Million	107,867 Added 5.04%	2,246,752 $649 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $103 Million - $115 Million	377,717 Added 21.45%	2,138,885 $619 Million
Q2 2022 Aug 12, 2022	BUY	$234.96 - $292.55 $12.6 Million - $15.7 Million	53,800 Added 3.15%	1,761,168 $496 Million
Q1 2022 May 13, 2022	BUY	$221.42 - $260.97 $17.8 Million - $21 Million	80,500 Added 4.95%	1,707,368 $446 Million
Q4 2021 Feb 11, 2022	SELL	$177.01 - $223.45 $46.8 Million - $59.1 Million	-264,618 Reduced 13.99%	1,626,868 $357 Million
Q3 2021 Nov 12, 2021	SELL	$181.39 - $202.99 $70 Million - $78.3 Million	-385,798 Reduced 16.94%	1,891,486 $343 Million
Q2 2021 Aug 13, 2021	SELL	$187.49 - $221.1 $23.1 Million - $27.2 Million	-123,000 Reduced 5.12%	2,277,284 $459 Million
Q1 2021 May 13, 2021	SELL	$207.02 - $241.31 $243 Million - $284 Million	-1,175,646 Reduced 32.88%	2,400,284 $516 Million
Q4 2020 Feb 10, 2021	SELL	$207.01 - $276.09 $338 Million - $450 Million	-1,631,002 Reduced 31.32%	3,575,930 $845 Million
Q3 2020 Nov 13, 2020	SELL	$255.65 - $303.1 $147 Million - $174 Million	-574,400 Reduced 9.94%	5,206,932 $1.42 Billion
Q2 2020 Aug 13, 2020	SELL	$225.48 - $295.8 $243 Million - $319 Million	-1,078,350 Reduced 15.72%	5,781,332 $1.68 Billion
Q1 2020 May 14, 2020	SELL	$199.77 - $247.81 $43.3 Million - $53.7 Million	-216,900 Reduced 3.07%	6,859,682 $1.63 Billion
Q4 2019 Feb 13, 2020	BUY	$166.71 - $223.91 $213 Million - $286 Million	1,277,465 Added 22.03%	7,076,582 $1.55 Billion
Q3 2019 Nov 13, 2019	BUY	$166.23 - $187.09 $40.4 Million - $45.5 Million	243,300 Added 4.38%	5,799,117 $982 Million
Q2 2019 Aug 12, 2019	BUY	$164.61 - $190.37 $78.5 Million - $90.8 Million	477,100 Added 9.39%	5,555,817 $1.02 Billion
Q1 2019 May 14, 2019	BUY	$163.73 - $194.7 $122 Million - $145 Million	744,417 Added 17.18%	5,078,717 $934 Million
Q4 2018 Feb 13, 2019	BUY	$151.91 - $192.21 $658 Million - $833 Million	4,334,300 New	4,334,300 $718 Million

Others Institutions Holding VRTX

# of Institutions

1,625

Shares Held

222M

Call Options Held

1.35M

Put Options Held

1.49M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $114B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account